Invesco Ltd (NYSE:IVZ):
Invesco Ltd. Announces June 30, 2017 Assets Under Management.
In the market the company is trading up since yesterday’s close of $35.72.
Additionally Invesco Ltd announced a dividend that was paid on Fri Jun 2, 2017. The dividend payment was $0.290 per share for the quarter or $1.16 on an annualized basis. This dividend amount represented a yeild of $3.30. The ex-dividend date was set for Wednesday the 10th of May 2017.
Invesco Ltd. (Invesco), launched on September 12, 2007, is an independent investment management company. The Company provides a range of investment capabilities and outcomes, which are delivered through a set of investment vehicles, to help clients achieve their investment objectives. The Company has a presence in the retail and institutional markets within the investment management industry in North America; Europe, Middle East and Africa (EMEA), and Asia-Pacific. It served clients in more than 100 countries, as of December 31, 2016. The Business’s Jemstep solution provides wealth management home offices and their advisors with a suite of technology solutions that are customizable and are integrated into existing systems. The solution offers advisors an open architecture platform that includes Invesco’s fundamental and factor-based investment strategies..
The stock is trading at $36.11 which is just a bit higher than the 50 day moving average which is $33.32 and which is marginally over the 200 day moving average of $31.84. The 50 day moving average moved up $2.79 whereas the 200 day average was up by +13.43%.
Invesco Ltd currently has a P/E ratio of 16.43 and the market value is 14.69B. As of the last earnings report the EPS was $2.20 and is expected to be $2.51 for the current year with 406,856,000 shares now outstanding. Next quarter’s EPS is estimated at $0.65 with next year’s EPS anticipated to be $2.82.
Analysts have released ratings on the company of late. On July 7 Jefferies held the stock rating at “Buy” but moved up the price target from $37.00 to $40.00. Equity analyst RBC Capital added IVZ to its research portfolio with an initial rating of “Outperform”.
On June 5, 2017 the stock rating was rated “Buy” by Citigroup a boost from the previous “Neutral” rating. On December 13 the company was downgraded to “Market Perform” from “Outperform” in an announcement from Keefe Bruyette & Woods.
Deutsche Bank downgraded the stock and lowered the price target on October 14 cutting the price target from $36.00 to $32.00 and altering the rating from “Buy” to “Hold”. On October 14 the stock rating was downgraded from “Buy” to “Hold” and a price target of $32.00 was set by analysts at Deutsche Bank.